David Barrington, MD, discusses the next steps for oncologists treating patients with stage 1B, grade 3 endometrial cancer.
David Barrington, MD
Advertisement
David Barrington, MD, is a surgical oncologist with a focus in gynecologic oncology at Ochsner MD Anderson Cancer Center.
Articles by David Barrington, MD
David Barrington, MD, discusses the results investigators found in determining treatment patterns and recommendations for patients with endometrial cancer.
David Barrington, MD, discusses the key takeaways regarding the factors associated with variation of adjuvant treatments for patients with stage 1B, grade 3 endometrial cancer.
David Barrington, MD, discusses his advice on molecular testing for patients with stage 1B, grade 3 endometrial cancer.
David Barrington, MD, discusses adjuvant treatments that are currently available for patients with stage 1B, grade 3 endometrial cancer.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
4
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
5
